| Common Name | Hu5F9-G4 |
|---|---|
| Synonyms | CD47;MER6;IAP |
| Applications | ELISA; Flow Cyt |
| Recommended Dilutions | ELISA 1:5000-10000; Flow Cyt 1:100 |
| Formulation & Reconstitution | Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
| Host Species | Homo sapiens |
| IgG type | IgG1 |
| Reactivity | Human |
| Target | |
| Uniprot ID | Q08722 |
| Description | Anti-CD47 (magrolimab biosimilar; IgG1) mAb |
| Delivery | In Stock |
| Storage & Shipping | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature. |
| Background | Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
| Usage | Research use only |
Anti-CD47 (magrolimab biosimilar;IgG1) mAb
Price: 50μg $80.00 ; 100 μg $160.00
Product Data
Images
Figure 1. ELISA plate pre-coated by 1 μg/ml (100 μl/well) Human CD47, mFc-His tagged protein (PME100008) can bind Anti-CD47（magrolimab biosimilar，IgG1） (BME100050) in a linear range of 3.2-16.0 ng/ml.
Figure 2. Jurkat cell line were surface stained with anti-CD47 (BME100050) (Blue histogram) and isotype control (Red histogram) 1μg/ml followed by Alexa 488-conjugated Goat anti-Human IgG secondary antibody.